Related Experiment Video
Updated: Jul 18, 2026
06:33
3-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii
Published on: December 9, 2014
11.5K
Current challenges in neurocysticercosis: recent data and where we are heading
Christina M Coyle1, Javier A Bustos2, Hector H Garcia3,4
1Department of Infectious Diseases, Albert Einstein College of Medicine, Bronx, New York, USA.
Current Opinion in Infectious Diseases
|August 1, 2024
Summary
Neurocysticercosis (NCC) diagnosis and management require careful consideration of imaging and serology. Optimizing anti-seizure and anti-inflammatory treatments can reduce complications and epilepsy risk.
Area of Science:
- Neurology
- Infectious Diseases
- Parasitology
Background:
- Neurocysticercosis (NCC) is a major cause of neurological disease globally.
- NCC is increasingly diagnosed in non-endemic regions due to migration.
- Clinicians need updated knowledge on NCC diagnosis and management.
Purpose of the Study:
- To review current diagnostic and therapeutic strategies for neurocysticercosis.
- To highlight the complexities in diagnosing and managing NCC.
- To inform clinicians in both endemic and non-endemic areas.
Main Methods:
- Assessment of recent data on imaging and immunodiagnostic tools.
- Evaluation of antiparasitic and anti-inflammatory therapeutic regimens.
- Review of literature on diagnostic precision and therapeutic efficacy.
Main Results:
- Diagnostic accuracy depends on assessing imaging and serology within the context of specific NCC types.
- Further controlled data is needed on the efficacy and safety of combination antiparasitic therapies.
- Optimization of antiseizure and anti-inflammatory treatments is crucial.
Conclusions:
- Improved diagnostic precision for NCC requires tailored assessment of imaging and serology.
- Further research is essential for combined antiparasitic therapy efficacy and safety.
- Optimized anti-inflammatory and antiseizure strategies can mitigate perilesional damage and epilepsy risk.
Related Concept Videos
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...